Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...